The purpose of this study is to learn more about the use of an investigational product, for the treatment of treatment-resistant depression. We want to determine if the investigational product can help to improve the symptoms of people with treatment-resistant depression. People with treatment-resistant depression have been prescribed antidepressants for depression (specifically major depressive disorder) previously, but their symptoms have not improved.
CONTACT US ABOUT DEPRESSION TRIALTreatment Resistant Depression
Description
Eligibility Criteria
18-65 Years Old; Currently experiencing a major depressive episode; Tried two or more antidepressants without an adequate response; Onset of first episode of MDD occurred before age 55;
Duration
Up to 155 Days (including Screening and Safety Follow-up Periods)
Categories
- Adult Clinical Trial